This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Sanofi. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: Mandy Mohnicke: Innovator in Pharmaceutical Chemistry
Introduction
Mandy Mohnicke is a prominent inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. Her work focuses on the development of novel compounds that have potential applications in medical treatments.
Latest Patents
Mohnicke's latest patents include innovative formulations that enhance the efficacy of pharmaceutical compounds. One of her notable inventions is related to crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide. This invention pertains to polymorphs and hydrates of the compound, detailing processes for their preparation and use in pharmaceutical compositions. Another significant patent involves crystalline solvates of 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride, which also includes processes for their preparation and application.
Career Highlights
Mandy Mohnicke is currently employed at Sanofi, a leading global biopharmaceutical company. Her role involves extensive research and development in the pharmaceutical sector, where she applies her expertise to create innovative solutions for healthcare challenges.
Collaborations
Throughout her career, Mohnicke has collaborated with esteemed colleagues, including Bruno Baumgartner and Norbert Nagel. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Mandy Mohnicke's contributions to pharmaceutical chemistry exemplify her dedication to innovation and research. Her patents reflect her commitment to advancing medical science and improving patient outcomes.